CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Sarcoma, Myeloid

An extramedullary tumor of immature MYELOID CELLS or MYELOBLASTS. Granulocytic sarcoma usually occurs with or follows the onset of ACUTE MYELOID LEUKEMIA.

Drugs by status

Phase 3 trials (7)

  • sorafenib
  • daunorubicin
  • bortezomib
  • etoposide
  • cytarabine
  • asparaginase
  • mitoxantrone

Phase 2 trials (32)

  • metformin
  • cladribine
  • azacitidine
  • dexrazoxane
  • allogeneic natural killer cells
  • plerixafor
  • venetoclax
  • blinatumomab
  • busulfan
  • clofarabine
  • devimistat
  • gemtuzumab ozogamicin
  • tacrolimus
  • aldesleukin
  • idarubicin
  • allogeneic hematopoietic stem cells
  • sirolimus
  • mycophenolate
  • cyclophosphamide
  • stem cells
  • t cell depleted hematopoietic stem cells
  • Anti-thymocyte Globulin (Rabbit)
  • vosaroxin
  • cd45-depleted allogenic peripheral blood stem cell
  • mesna
  • fludarabine
  • rituximab
  • thiotepa
  • sargramostim
  • melphalan
  • +2 more

Phase 1 trials (1)

  • ziftomenib

Organizations

Organization Involved with Phase 3 Indications (1)

  • National Cancer Institute (NCI)

Organization Involved with Phase 2 Indications (5)

  • Wake Forest University
  • Vanderbilt University
  • University of Texas at Houston
  • Assisi Foundation
  • St. Jude Children's Hospital

ICD-10 crosswalk

  • C92.3 — Myeloid sarcoma

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.